Til transaksjoner
Helse & omsorg

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Januar 2025 — Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Dimainvest is a holding company owned by Umberto Di Maio, the controlling shareholder of Shedir Pharma Group.

Shedir Pharma Group manufactures and distributes nutraceuticals, cosmetics and medical devices. The company is headquartered in Piano di Sorrento, Italy.

Vår rolle i transaksjonen

Oaklins Italy’s parent company, Banca Akros, acted as the appointed broker for the collection of shares in the voluntary public tender offer for 11.9% of Shedir Pharma Group’s shares by Dimainvest.

TRANSAKSJONSTYPE
Parter

Kontakt ansvarlige rådgivere

Giulio Greco

Managing Director
Milano, Italia
Oaklins Italy

Nicola Vulcano

Director
Milano, Italia
Oaklins Italy

Marco Valsecchi

Associate
Milano, Italia
Oaklins Italy

Rita Vizzi

Associate
Milano, Italia
Oaklins Italy

Relaterte transaksjoner

OEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value
Private equity | TMT

OEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value

OEP Danzig BidCo S.p.A. has completed a mandatory tender offer for the shares of Digital Value S.p.A.

Les mer
Verdane has completed the acquisition of Augmentum Fintech
Finansielle tjenester

Verdane has completed the acquisition of Augmentum Fintech

Following the acceptance of its offer and subsequent shareholder approval, Augmentum Fintech plc has been acquired by Verdane Advisors AS.

Les mer
UKAT Group has acquired Bayberry Limited
Private equity | Helse & omsorg

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Les mer